Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Not applicableUnknownNCT06483490
What this trial is testing

Environmental Pollutants in COPD and Lung Cancer

Who this might be right for
COPD and Lung Cancer
University of Campania Luigi Vanvitelli 200
Large-scale testing (Phase 3)UnknownNCT01555710
What this trial is testing

Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell Lung Cancer (The MATISSE Study)

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Alaunos Therapeutics 548
Testing effectiveness (Phase 2)Active Not RecruitingNCT06745323
What this trial is testing

A Phase 2, Open-label, Randomized, Multicenter Study of Tarlatamab Dosing Regimens in Subjects With SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
Amgen 252
Testing effectiveness (Phase 2)UnknownNCT03904823
What this trial is testing

Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC

Who this might be right for
EGFR-mutant Non-Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 58
Not applicableStudy completedNCT03891602
What this trial is testing

DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement

Who this might be right for
SmokingSmoking, TobaccoSmoking, Cigarette+1 more
Hackensack Meridian Health 654
Testing effectiveness (Phase 2)Study completedNCT04466098
What this trial is testing

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeARDS (Moderate or Severe)COVID-19 Pneumonia
Masonic Cancer Center, University of Minnesota 8
Not applicableUnknownNCT02709863
What this trial is testing

Comparison of The Effects of Sevoflurane, Desflurane and Total Intravenous Anaesthesia on Pulmonary Function Tests

Who this might be right for
Pituitary Adenoma
Istanbul University 90
Testing effectiveness (Phase 2)Looking for participantsNCT05987644
What this trial is testing

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

Who this might be right for
Lung CancerNSCLCBrain Metastases
Joshua Palmer 56
Not applicableStudy completedNCT04125381
What this trial is testing

Arsenic Exposure and Lung Cancer Incidence

Who this might be right for
Incident Cases of Lung Cancer (Code ICD-O C340-C349)
University of Rome Tor Vergata 314,000
Early research (Phase 1)Active Not RecruitingNCT04197934
What this trial is testing

WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Who this might be right for
Anaplastic Astrocytoma, IDH-WildtypeGlioblastoma, IDH-WildtypeMetastatic Lung Non-Small Cell Carcinoma+2 more
Mayo Clinic 56
Early research (Phase 1)Looking for participantsNCT07646106
What this trial is testing

THE-0504 in Patients With Solid Tumors

Who this might be right for
Small Cell Lung Cancer (SCLC)Colorectal Carcinoma (CRC)Gastric Cancer (GC)+2 more
Thena Biotech S.r.l. 30
Early research (Phase 1)Not Yet RecruitingNCT06941480
What this trial is testing

177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate

Who this might be right for
Neuroendocrine Tumor of the LungNeuroendocrine Carcinoma of LungNeuroendocrine Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT05810350
What this trial is testing

Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles

Who this might be right for
Non-small Cell Lung Cancer
Three Gorges Hospital of Chongqing University 40
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableStudy completedNCT02250755
What this trial is testing

MRI Perfusion on T1 and T2 Brain Lesion(s)

Who this might be right for
Lung Carcinoma Metastatic to the Brain
University Hospital, Lille 30
Not applicableEnded earlyNCT03849950
What this trial is testing

Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)

Who this might be right for
LymphomaLung CancerColo-rectal Cancer
University Health Network, Toronto 62
Not applicableActive Not RecruitingNCT05150210
What this trial is testing

SP Thoracic IDE Study

Who this might be right for
Primary Lung CancerBenign Lung DiseaseThymoma+1 more
Intuitive Surgical 32
Not applicableStudy completedNCT07239102
What this trial is testing

Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis

Who this might be right for
EGFR Positive Non-small Cell Lung CancerCentral Nervous System MetastasisLeptomeningeal Metastasis
Beijing Tiantan Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT00526890
What this trial is testing

Carboplatin, Paclitaxel, Selenomethionine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung Cancer
Roswell Park Cancer Institute 16
Next Page